Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Zarruk JG
- Fernández-López D
- García-Yébenes I
- García-Gutiérrez MS
- Lizasoain I
- Moro MA
Abstract
Ischemic stroke continues to be one of the main causes of death worldwide. Inflammation accounts for a large part of damage in this pathology. The cannabinoid type 2 receptor (CB2R) has been proposed to have neuroprotective properties in neurological diseases. Therefore, our aim was to determine the effects of the activation of CB2R on infarct outcome and on ischemia-induced brain expression of classic and alternative markers of macrophage/microglial activation.
Datos de la publicación
- ISSN/ISSNe:
- 0039-2499, 1524-4628
- Tipo:
- Article
- Páginas:
- 211-219
- PubMed:
- 22020035
- Factor de Impacto:
- 3,912 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Stroke LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 185
Documentos
- No hay documentos
Filiaciones
Keywords
- ischemic stroke; MCAO; mouse; cannabinoid; microglia; alternative phenotype
Portal de investigación